Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation

Spinal Cord Injury Clinical Trial

Official title:

Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02104622
• Other study ID #: 89259
• Status: Completed
• Phase: N/A
• Start date: February 2014
• Est. completion date: January 2020

Study information

• Verified date: May 2020
• Source: Shirley Ryan AbilityLab
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Many people with spinal cord injury are no longer able to walk and must use wheelchairs for mobility. These individuals experience greater rates of depression and lower quality of life. Many of these individuals express a strong desire to walk again, and report many psychosocial benefits to being eye to eye with peers in social interactions. Additionally, wheelchairs allow only limited community access, creating an additional obstacle to seeking out meaningful social roles in the community. Currently, there is new technology called robotic exoskeletons that would allow people with spinal cord injury to walk. These robotic exoskeletons also allow for curb, ramp, and stair negotiation, which are critical to community access. Current research has examined training with robotic exoskeletons indoors over level surfaces in clinical settings. This study will examine the potential for everyday use, including ramps, stairs, curbs and indoor and outdoor use.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: January 2020
• Est. primary completion date: January 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 85 Years

Eligibility

Inclusion Criteria:

• SCI level C6-8, T1-T12; L1-L5 incomplete or complete

• Be able to physically fit into the exoskeleton device;

• Be able to tolerate upright standing for a minimum of 30 minutes;

• Have sufficient upper body strength to use forearm crutches in standing and during ambulation (including full triceps strength and good hand function);

• Have hip, knee, and ankle range of motion within normal functional limits of walking;

• Have the ability to follow directions and demonstrate learning capacity;

• Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

• Cervical level SCI above C6

• History of severe osteoporosis;

• Weight above 220 pounds;

• Femur length above 47 cm or below 36 cm

• Joint contractures at the hip, knee, or ankle that limit normal range of motion (ROM) during ambulation;

• Cognitive and/or communication disability (e.g. due to brain injury);

• History of significant problems with skin break down or current skin break down;

• Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity);

• Pregnancy;

• Cardiovascular conditions such as history of heart attack, high blood pressure, pacemaker, arrhythmia, heart failure, or stroke.

Related Conditions & MeSH terms

• Spinal Cord Injuries
• Spinal Cord Injury

Intervention

Device:
• ReWalk Rehabilitation 2.0

Locations

Country	Name	City	State
United States	Rehabilitation Institute of Chicago	Chicago	Illinois

Sponsors (2)

Lead Sponsor	Collaborator
Shirley Ryan AbilityLab	U.S. Department of Education

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in 6 Minute Walk Test from baseline in distance, RPE and oxygen uptake	The goal is to cover as much ground as possible over 6 minutes, the distance is measured with a measuring wheel. The instructions are "Walk continuously if possible, but do not be concerned if you need to slow down or stop to rest." At the end of 6 minutes the participant is asked to rate their exertion level on a Borg Scale of 6 - 20 points. The VO2 MAX data is collected during the test every 10 seconds	Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Primary	Change in 10 meter walk test from baseline in gait speed	Measure the time in second for and individual to walk 10 meters. The test is Performed using a "flying start," patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: " Please walk this distance as fast as you safely can when I say go."	Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Primary	Time and assistive level to negotiate stairs, ramps, curbs, and turning.		Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Primary	Distance able to reach while standing and sitting		Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Secondary	Patient perception of Quality of Life		Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Secondary	The Patient Health Questionnaire	PHQ-9 is a 9-item self-report questionnaire designed to diagnose both the presence of depressive symptoms as well as to characterize the severity of depression. A single question rates how difficult problems have made it to do work, take care of things at home or get along with other people using a 4 level scale (not difficult at all to extremely difficult).	Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Secondary	The Psychosocial Impact of Assistive Devices Scale	The PIADS is a 26-item, self-report questionnaire designed to assess the effects of an assistive device on functional independence, well-being, and quality of life. The PIADS can be used to assess the impact of any assistive device (AD), prosthesis or medical procedure. It can be used to evaluate the impact of ADs over time and to match the devices with consumers. With its excellent psychometric properties, the PIADS fills a missing link in the assessment of ADs as well as in the examination of their acceptance and abandonment.	Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Secondary	Activities-specific Balance Confidence Scale		Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Secondary	Self reported Spinal Cord Independence Measure in activities of daily living		Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Secondary	Pain measure by the Visual Analogue Scale		Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)